一种用于治疗肺部炎症相关疾病的中药组合物及其用途
A traditional Chinese medicine combination of glycyrrhizic acid, baicalein, and 6-shogaol has solved the treatment challenges of lung inflammation-related diseases, achieving safe and effective treatment results while avoiding the toxic side effects of hormones. It is suitable for pneumonia and acute lung injury caused by various factors.
CN117731678BActive Publication Date: 2026-07-17XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI +1
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI
- Filing Date
- 2023-11-13
- Publication Date
- 2026-07-17
Smart Images
Figure CN117731678B_ABST
Abstract
本发明提供了一种用于治疗肺部炎症相关疾病的中药组合物，其包含甘草酸、黄芩素和6‑姜烯酚。本发明的中药组合物是基于多种中药有效成分的组合，可多靶点、多层次协同发挥作用，多成分组合可克服单一成分治疗的有限疗效、不良反应和耐药性，而且有效剂量范围无毒副作用，可确保临床用药安全，尤其对于不适用激素的患者，扩大了临床使用范围。另外，本发明是中药有效成分组合物，成分明确，成分间的相互作用明确，药效和安全性高于成分复杂的传统中药复方。
Need to check novelty before this filing date? Find Prior Art